Its removal from Category 1 means it is moving into the PCAC review pipeline for a definitive determination rather than remaining in the indefinite "under evaluation" holding pattern
You're left with another 13 [million]
Eli Lillys tirzepatide drugs face the same criticism, since the Mounjaro label lists general gastrointestinal issues but not the severe stomach paralysis or bowel obstruction described in patient reports
Serving size: 2 capsules Servings per container: 60 *RI = EU reference intake **No RI available INGREDIENTS: Glutathione, capsule (hydroxypropyl methyl cellulose), calcium phosphates, bulking agent (microcrystalline cellulose/cellulosegel)), anti-caking agents (silicon dioxide [nano], magnesium salts of fatty acids) non-GMO OPITAC is the trademark for L-Glutathione of Mitsubishi Corporation Life Sciences Limited
Generation of these variants in cell culture showed a reduced PI(3,4)P2-synthesizing ability, as well as impaired production of PI(3)P